ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Critical Care Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24D13619
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Critical Care Therapeutics Market Insights Forecast to 2029
BUY CHAPTERS

Global Critical Care Therapeutics Market Research Report 2025

Code: QYRE-Auto-24D13619
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Kedrion Biopharma
Octapharma AG
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai Raas
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Grifols S A
CSL Behring

Critical Care Therapeutics Market Size

The global market for Critical Care Therapeutics was valued at US$ 3123 million in the year 2024 and is projected to reach a revised size of US$ 3649 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Critical Care Therapeutics Market

Critical Care Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Critical Care Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Critical Care Therapeutics.
The Critical Care Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Critical Care Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Critical Care Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Critical Care Therapeutics Market Report

Report Metric Details
Report Name Critical Care Therapeutics Market
Accounted market size in year US$ 3123 million
Forecasted market size in 2031 US$ 3649 million
CAGR 2.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Takeda, Bayer HealthCare, Merck, Mitsubishi Tanabe Pharma, REVO Biologics, Rockwell Medical, Thermo Fisher Scientific, Shanghai RAAS, China Biologic Products, Cosmo Pharmaceuticals, King Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Critical Care Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Critical Care Therapeutics Market growing?

Ans: The Critical Care Therapeutics Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Critical Care Therapeutics Market size in 2031?

Ans: The Critical Care Therapeutics Market size in 2031 will be US$ 3649 million.

Who are the main players in the Critical Care Therapeutics Market report?

Ans: The main players in the Critical Care Therapeutics Market are CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Takeda, Bayer HealthCare, Merck, Mitsubishi Tanabe Pharma, REVO Biologics, Rockwell Medical, Thermo Fisher Scientific, Shanghai RAAS, China Biologic Products, Cosmo Pharmaceuticals, King Pharmaceuticals

What are the Application segmentation covered in the Critical Care Therapeutics Market report?

Ans: The Applications covered in the Critical Care Therapeutics Market report are Pulmonary Embolism (PE), Acute Coronary Syndrome, Atrial Fibrillation, Other

What are the Type segmentation covered in the Critical Care Therapeutics Market report?

Ans: The Types covered in the Critical Care Therapeutics Market report are Albumin, Prothrombin Complex Concentrates, Antithrombin Concentrates, Factor XIII Concentrates, Fibrinogen Concentrates

Recommended Reports

Critical Care Drugs

Pulmonary Therapeutics

Oncology & Cell Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Critical Care Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Albumin
1.2.3 Prothrombin Complex Concentrates
1.2.4 Antithrombin Concentrates
1.2.5 Factor XIII Concentrates
1.2.6 Fibrinogen Concentrates
1.3 Market by Application
1.3.1 Global Critical Care Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pulmonary Embolism (PE)
1.3.3 Acute Coronary Syndrome
1.3.4 Atrial Fibrillation
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Critical Care Therapeutics Market Perspective (2020-2031)
2.2 Global Critical Care Therapeutics Growth Trends by Region
2.2.1 Global Critical Care Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Critical Care Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Critical Care Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Critical Care Therapeutics Market Dynamics
2.3.1 Critical Care Therapeutics Industry Trends
2.3.2 Critical Care Therapeutics Market Drivers
2.3.3 Critical Care Therapeutics Market Challenges
2.3.4 Critical Care Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Critical Care Therapeutics Players by Revenue
3.1.1 Global Top Critical Care Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Critical Care Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Critical Care Therapeutics Revenue
3.4 Global Critical Care Therapeutics Market Concentration Ratio
3.4.1 Global Critical Care Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Critical Care Therapeutics Revenue in 2024
3.5 Global Key Players of Critical Care Therapeutics Head office and Area Served
3.6 Global Key Players of Critical Care Therapeutics, Product and Application
3.7 Global Key Players of Critical Care Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Critical Care Therapeutics Breakdown Data by Type
4.1 Global Critical Care Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Critical Care Therapeutics Forecasted Market Size by Type (2026-2031)
5 Critical Care Therapeutics Breakdown Data by Application
5.1 Global Critical Care Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Critical Care Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Critical Care Therapeutics Market Size (2020-2031)
6.2 North America Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Critical Care Therapeutics Market Size by Country (2020-2025)
6.4 North America Critical Care Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Critical Care Therapeutics Market Size (2020-2031)
7.2 Europe Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Critical Care Therapeutics Market Size by Country (2020-2025)
7.4 Europe Critical Care Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Critical Care Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Critical Care Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Critical Care Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Critical Care Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Critical Care Therapeutics Market Size (2020-2031)
9.2 Latin America Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Critical Care Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Critical Care Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Critical Care Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Critical Care Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Critical Care Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Critical Care Therapeutics Introduction
11.1.4 CSL Behring Revenue in Critical Care Therapeutics Business (2020-2025)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Critical Care Therapeutics Introduction
11.2.4 Grifols Revenue in Critical Care Therapeutics Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Kedrion Biopharma
11.3.1 Kedrion Biopharma Company Details
11.3.2 Kedrion Biopharma Business Overview
11.3.3 Kedrion Biopharma Critical Care Therapeutics Introduction
11.3.4 Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2020-2025)
11.3.5 Kedrion Biopharma Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Critical Care Therapeutics Introduction
11.4.4 Octapharma Revenue in Critical Care Therapeutics Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Critical Care Therapeutics Introduction
11.5.4 Takeda Revenue in Critical Care Therapeutics Business (2020-2025)
11.5.5 Takeda Recent Development
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Details
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Critical Care Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Critical Care Therapeutics Business (2020-2025)
11.6.5 Bayer HealthCare Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Critical Care Therapeutics Introduction
11.7.4 Merck Revenue in Critical Care Therapeutics Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Mitsubishi Tanabe Pharma
11.8.1 Mitsubishi Tanabe Pharma Company Details
11.8.2 Mitsubishi Tanabe Pharma Business Overview
11.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Introduction
11.8.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2020-2025)
11.8.5 Mitsubishi Tanabe Pharma Recent Development
11.9 REVO Biologics
11.9.1 REVO Biologics Company Details
11.9.2 REVO Biologics Business Overview
11.9.3 REVO Biologics Critical Care Therapeutics Introduction
11.9.4 REVO Biologics Revenue in Critical Care Therapeutics Business (2020-2025)
11.9.5 REVO Biologics Recent Development
11.10 Rockwell Medical
11.10.1 Rockwell Medical Company Details
11.10.2 Rockwell Medical Business Overview
11.10.3 Rockwell Medical Critical Care Therapeutics Introduction
11.10.4 Rockwell Medical Revenue in Critical Care Therapeutics Business (2020-2025)
11.10.5 Rockwell Medical Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Critical Care Therapeutics Introduction
11.11.4 Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Shanghai RAAS
11.12.1 Shanghai RAAS Company Details
11.12.2 Shanghai RAAS Business Overview
11.12.3 Shanghai RAAS Critical Care Therapeutics Introduction
11.12.4 Shanghai RAAS Revenue in Critical Care Therapeutics Business (2020-2025)
11.12.5 Shanghai RAAS Recent Development
11.13 China Biologic Products
11.13.1 China Biologic Products Company Details
11.13.2 China Biologic Products Business Overview
11.13.3 China Biologic Products Critical Care Therapeutics Introduction
11.13.4 China Biologic Products Revenue in Critical Care Therapeutics Business (2020-2025)
11.13.5 China Biologic Products Recent Development
11.14 Cosmo Pharmaceuticals
11.14.1 Cosmo Pharmaceuticals Company Details
11.14.2 Cosmo Pharmaceuticals Business Overview
11.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Introduction
11.14.4 Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025)
11.14.5 Cosmo Pharmaceuticals Recent Development
11.15 King Pharmaceuticals
11.15.1 King Pharmaceuticals Company Details
11.15.2 King Pharmaceuticals Business Overview
11.15.3 King Pharmaceuticals Critical Care Therapeutics Introduction
11.15.4 King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025)
11.15.5 King Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Kedrion Biopharma
Octapharma AG
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai Raas
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Grifols S A
CSL Behring
List of Tables
 Table 1. Global Critical Care Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Albumin
 Table 3. Key Players of Prothrombin Complex Concentrates
 Table 4. Key Players of Antithrombin Concentrates
 Table 5. Key Players of Factor XIII Concentrates
 Table 6. Key Players of Fibrinogen Concentrates
 Table 7. Global Critical Care Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Critical Care Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Critical Care Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Critical Care Therapeutics Market Share by Region (2020-2025)
 Table 11. Global Critical Care Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Critical Care Therapeutics Market Share by Region (2026-2031)
 Table 13. Critical Care Therapeutics Market Trends
 Table 14. Critical Care Therapeutics Market Drivers
 Table 15. Critical Care Therapeutics Market Challenges
 Table 16. Critical Care Therapeutics Market Restraints
 Table 17. Global Critical Care Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Critical Care Therapeutics Market Share by Players (2020-2025)
 Table 19. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2024)
 Table 20. Ranking of Global Top Critical Care Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Critical Care Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Critical Care Therapeutics, Headquarters and Area Served
 Table 23. Global Key Players of Critical Care Therapeutics, Product and Application
 Table 24. Global Key Players of Critical Care Therapeutics, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Critical Care Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Critical Care Therapeutics Revenue Market Share by Type (2020-2025)
 Table 28. Global Critical Care Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Critical Care Therapeutics Revenue Market Share by Type (2026-2031)
 Table 30. Global Critical Care Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Critical Care Therapeutics Revenue Market Share by Application (2020-2025)
 Table 32. Global Critical Care Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Critical Care Therapeutics Revenue Market Share by Application (2026-2031)
 Table 34. North America Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Critical Care Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Critical Care Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Critical Care Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 49. CSL Behring Company Details
 Table 50. CSL Behring Business Overview
 Table 51. CSL Behring Critical Care Therapeutics Product
 Table 52. CSL Behring Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 53. CSL Behring Recent Development
 Table 54. Grifols Company Details
 Table 55. Grifols Business Overview
 Table 56. Grifols Critical Care Therapeutics Product
 Table 57. Grifols Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 58. Grifols Recent Development
 Table 59. Kedrion Biopharma Company Details
 Table 60. Kedrion Biopharma Business Overview
 Table 61. Kedrion Biopharma Critical Care Therapeutics Product
 Table 62. Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 63. Kedrion Biopharma Recent Development
 Table 64. Octapharma Company Details
 Table 65. Octapharma Business Overview
 Table 66. Octapharma Critical Care Therapeutics Product
 Table 67. Octapharma Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 68. Octapharma Recent Development
 Table 69. Takeda Company Details
 Table 70. Takeda Business Overview
 Table 71. Takeda Critical Care Therapeutics Product
 Table 72. Takeda Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 73. Takeda Recent Development
 Table 74. Bayer HealthCare Company Details
 Table 75. Bayer HealthCare Business Overview
 Table 76. Bayer HealthCare Critical Care Therapeutics Product
 Table 77. Bayer HealthCare Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 78. Bayer HealthCare Recent Development
 Table 79. Merck Company Details
 Table 80. Merck Business Overview
 Table 81. Merck Critical Care Therapeutics Product
 Table 82. Merck Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 83. Merck Recent Development
 Table 84. Mitsubishi Tanabe Pharma Company Details
 Table 85. Mitsubishi Tanabe Pharma Business Overview
 Table 86. Mitsubishi Tanabe Pharma Critical Care Therapeutics Product
 Table 87. Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 88. Mitsubishi Tanabe Pharma Recent Development
 Table 89. REVO Biologics Company Details
 Table 90. REVO Biologics Business Overview
 Table 91. REVO Biologics Critical Care Therapeutics Product
 Table 92. REVO Biologics Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 93. REVO Biologics Recent Development
 Table 94. Rockwell Medical Company Details
 Table 95. Rockwell Medical Business Overview
 Table 96. Rockwell Medical Critical Care Therapeutics Product
 Table 97. Rockwell Medical Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 98. Rockwell Medical Recent Development
 Table 99. Thermo Fisher Scientific Company Details
 Table 100. Thermo Fisher Scientific Business Overview
 Table 101. Thermo Fisher Scientific Critical Care Therapeutics Product
 Table 102. Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 103. Thermo Fisher Scientific Recent Development
 Table 104. Shanghai RAAS Company Details
 Table 105. Shanghai RAAS Business Overview
 Table 106. Shanghai RAAS Critical Care Therapeutics Product
 Table 107. Shanghai RAAS Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 108. Shanghai RAAS Recent Development
 Table 109. China Biologic Products Company Details
 Table 110. China Biologic Products Business Overview
 Table 111. China Biologic Products Critical Care Therapeutics Product
 Table 112. China Biologic Products Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 113. China Biologic Products Recent Development
 Table 114. Cosmo Pharmaceuticals Company Details
 Table 115. Cosmo Pharmaceuticals Business Overview
 Table 116. Cosmo Pharmaceuticals Critical Care Therapeutics Product
 Table 117. Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 118. Cosmo Pharmaceuticals Recent Development
 Table 119. King Pharmaceuticals Company Details
 Table 120. King Pharmaceuticals Business Overview
 Table 121. King Pharmaceuticals Critical Care Therapeutics Product
 Table 122. King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
 Table 123. King Pharmaceuticals Recent Development
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources
 Table 127. Authors List of This Report


List of Figures
 Figure 1. Critical Care Therapeutics Picture
 Figure 2. Global Critical Care Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Critical Care Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Albumin Features
 Figure 5. Prothrombin Complex Concentrates Features
 Figure 6. Antithrombin Concentrates Features
 Figure 7. Factor XIII Concentrates Features
 Figure 8. Fibrinogen Concentrates Features
 Figure 9. Global Critical Care Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Critical Care Therapeutics Market Share by Application: 2024 VS 2031
 Figure 11. Pulmonary Embolism (PE) Case Studies
 Figure 12. Acute Coronary Syndrome Case Studies
 Figure 13. Atrial Fibrillation Case Studies
 Figure 14. Other Case Studies
 Figure 15. Critical Care Therapeutics Report Years Considered
 Figure 16. Global Critical Care Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Critical Care Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Critical Care Therapeutics Market Share by Region: 2024 VS 2031
 Figure 19. Global Critical Care Therapeutics Market Share by Players in 2024
 Figure 20. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Critical Care Therapeutics Revenue in 2024
 Figure 22. North America Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Critical Care Therapeutics Market Share by Country (2020-2031)
 Figure 24. United States Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Critical Care Therapeutics Market Share by Country (2020-2031)
 Figure 28. Germany Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Critical Care Therapeutics Market Share by Region (2020-2031)
 Figure 36. China Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Critical Care Therapeutics Market Share by Country (2020-2031)
 Figure 44. Mexico Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Critical Care Therapeutics Market Share by Country (2020-2031)
 Figure 48. Turkey Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. CSL Behring Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 52. Grifols Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 53. Kedrion Biopharma Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 54. Octapharma Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 55. Takeda Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 56. Bayer HealthCare Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 57. Merck Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 58. Mitsubishi Tanabe Pharma Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 59. REVO Biologics Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 60. Rockwell Medical Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 62. Shanghai RAAS Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 63. China Biologic Products Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 64. Cosmo Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 65. King Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Still s Disease Treatment Market Research Report 2025
Global Sepsis Diagnostic Market Research Report 2024
Global Cardiovascular Disease Nursing Drugs Market Research Report 2025
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global Pharmerging Market Research Report 2025
Global Diagnostic Guidewire Market Research Report 2024
Global Pharmaceutical Asset Management Market Research Report 2025
Global Pharmaceutical Validation Services Market Research Report 2025
Global Anti Infectives Market Research Report 2025
Global Drug Stability Testing Services Market Research Report 2025
Global Chemical Dosing Units Market Research Report 2025
Global Pharma Contract Service Market Research Report 2025
Global CGT Drugs Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Global Asthma Therapeutics Market Research Report 2025
Critical Care Therapeutic Bed Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiogenic Shock Drug Market Research Report 2025
Global Pill Organizer with Timer Reminder Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions